Abstract

PurposeAdhesion formation after endometriosis surgery is a severe problem affecting up to 90% of patients. Possible complications include chronic pain, ileus, and secondary infertility. Therefore, effective adhesion prophylaxis is desirable, for which the adhesion barrier 4DryField® PH is evaluated in the present clinical study. It is a starch-based powder that forms a gel after irrigation with saline solution and thus separates surgical sites as physical barrier for adhesion prevention.MethodsFifty patients with extensive and deep infiltrating endometriosis were included in this prospective, randomized, controlled clinical trial with two-staged laparoscopic approach. The patients were randomized into two groups, one receiving 4DryField® PH and the other irrigation with saline solution for adhesion prevention. Adhesion formation was directly scored during second-look interventions considering incidence, extent, and severity. Adhesion prevention treatment in the second surgery was performed corresponding to the first intervention to evaluate the long-term outcome in the later course.ResultsBoth groups were comparable with respect to relevant patient parameters. Severity and extent of adhesions were significantly reduced by 85% in the 4DryField® PH group compared to the control group (mean total adhesion score 2.2 vs. 14.2; p = 0.004). Incidence of adhesion formation based on the number of affected sites was significantly reduced by 53% in the intervention vs. control group (mean 1.1 vs. 2.3 sites; p = 0.004). Follow-up of secondary endpoints is not yet completed; results will become available at a later stage.ConclusionAdhesion formation could be reduced significantly by 85% by application of the adhesion barrier 4DryField® PH.Trial registrationTrial registration main ID: DRKS00014720, secondary ID: U1111-1213-4142; date of registration 09th May 2018.

Highlights

  • Bernhard Krämer and Jürgen Andress contributed to this work.Some contents of this publication were presented at the 5th European Congress on Endometriosis (EEC) from December 05 to 07, 2019 in Prague, Czech Republic, the 63rd Congress of the German Society for Gynaecology and Obstetrics (DGGG) from October 07 to 10, 2020 in Munich, Germany, and at the European Society for Gynaecological Endoscopy (ESGE) 29th Annual Congress (Online Live Event December 06 to 08, 2020), where it was awarded Best Oral Presentation.Endometriosis affects between 10% and 15% of women of reproductive age [1]

  • The parameters extent and severity of adhesions as well as the adhesion incidence were analyzed in this clinical study

  • Severity and extent of adhesions that could be detected upon second look are summarized in the total adhesion score according to the calculation described above

Read more

Summary

Introduction

Bernhard Krämer and Jürgen Andress contributed to this work.Some contents of this publication were presented at the 5th European Congress on Endometriosis (EEC) from December 05 to 07, 2019 in Prague, Czech Republic, the 63rd Congress of the German Society for Gynaecology and Obstetrics (DGGG) from October 07 to 10, 2020 in Munich, Germany, and at the European Society for Gynaecological Endoscopy (ESGE) 29th Annual Congress (Online Live Event December 06 to 08, 2020), where it was awarded Best Oral Presentation.Endometriosis affects between 10% and 15% of women of reproductive age [1]. Bernhard Krämer and Jürgen Andress contributed to this work. Some contents of this publication were presented at the 5th European Congress on Endometriosis (EEC) from December 05 to 07, 2019 in Prague, Czech Republic, the 63rd Congress of the German Society for Gynaecology and Obstetrics (DGGG) from October 07 to 10, 2020 in Munich, Germany, and at the European Society for Gynaecological Endoscopy (ESGE) 29th Annual Congress (Online Live Event December 06 to 08, 2020), where it was awarded Best Oral Presentation. Endometriosis affects between 10% and 15% of women of reproductive age [1]. The most common accessory symptoms are infertility and the so-called endometriosis-associated pelvic pain, a term that commonly includes dysmenorrhea, noncyclical pelvic pain, deep dyspareunia, dyschezia, and chronic pelvic pain [2,3,4]. Other theories suspect coelomic metaplasia and hematogenous or lymphatic spread [5, 6]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call